Bunkerhill ECG-EF vs WellDoc BlueStar

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by WellDoc

AI Verdict

Bunkerhill ECG-EF is an AI algorithm designed for clinicians to detect reduced left ventricular ejection fraction from ECGs, aiding in early heart failure risk identification. In contrast, WellDoc BlueStar is a patient-facing digital health solution that provides personalized AI-powered coaching for chronic disease management, including heart failure, alongside other conditions like diabetes and hypertension. While both leverage AI in cardiology, Bunkerhill focuses on diagnostic support for providers, whereas WellDoc emphasizes patient self-management and education.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary need is a rapid, non-invasive AI-powered diagnostic aid to screen for reduced left ventricular ejection fraction (LVEF) from routine ECGs. This tool is ideal for clinical environments seeking to quickly identify patients at risk for heart failure within existing workflows, such as emergency departments or primary care, to facilitate earlier intervention.

View Bunkerhill ECG-EF →

Choose WellDoc BlueStar if…

Choose WellDoc BlueStar if your organization requires a comprehensive, AI-powered digital health solution for long-term chronic disease management and patient engagement. This platform is best suited for supporting patients with conditions like diabetes, hypertension, or heart failure through personalized coaching, integration with connected devices, and a mobile-first approach to improve self-management and clinical outcomes.

View WellDoc BlueStar →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF WellDoc BlueStar
Pricing Contact sales for pricing details. Unknown
Deployment Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. Mobile app, web-based HCP software, and integration with existing systems.
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill ECG-EF

Tool A integrates seamlessly with existing EHRs and clinical archives, functioning as a software-only medical device, which suggests a low-friction experience for clinicians within their current workflows. Tool B, while designed for user-friendliness, is a patient-facing mobile app requiring active patient engagement and device management, which can introduce more usability considerations for a broad user base.

Clinical Value

WellDoc BlueStar

Tool A offers significant diagnostic value by aiding in the early identification of heart failure risk from routine ECGs. However, Tool B provides broader and continuous clinical value through multi-condition support, personalized AI coaching, and specific treatment recommendations like insulin dosing, directly impacting patient self-management and long-term outcomes across several chronic diseases.

Pricing & Value

Tie

Both tools require direct contact for enterprise-level pricing, indicating a lack of public transparency. Without specific cost details or publicly available return on investment (ROI) data for either product, it is impossible to definitively determine which offers superior value.

Enterprise Readiness

Bunkerhill ECG-EF

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, establishing a strong foundation for enterprise readiness. Tool A's explicit focus on seamless integration with EHRs and clinical archives for diagnostic workflows suggests a more straightforward deployment and adoption within existing clinical infrastructure compared to managing a patient-facing mobile application across a large patient population.

Innovation

WellDoc BlueStar

While Tool A's application of AI to detect reduced LVEF from routine ECGs is innovative for diagnostic purposes, Tool B demonstrates broader innovation. Its multi-faceted AI approach for continuous, personalized chronic disease management across several conditions, including active treatment recommendations and extensive integration with connected devices, pushes the boundaries of patient engagement and self-management.

Support & Docs

WellDoc BlueStar

WellDoc provides more readily accessible and detailed support resources, including publicly available FAQs for both patients and providers, and direct contact information for app experts. In contrast, specific public support pages or detailed documentation for Bunkerhill Health were not readily found through web searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF WellDoc BlueStar
Name Bunkerhill ECG-EF WellDoc BlueStar
Company BunkerHill Health WellDoc
Description FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. FDA-cleared, AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure.
Key Features AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%); Analyzes routine 12-lead ECG data; Software-only medical device; Integrates with Electronic Medical Records (EMR) or ECG Management Systems (EMS); Part of the Carebricks platform for clinical reasoning and action; Aids in early identification of patients at risk for heart failure; Non-invasive, rapid, and accessible cardiac diagnostic tool; Supports automated clinical workflows AI-driven personalized coaching; Multi-condition support (diabetes, hypertension, heart failure, weight management, behavioral health); Integration with connected devices (BGM, CGM, BP cuffs, weight scales, activity trackers, insulin pens); Insulin dose recommendations (bolus, basal, premixed); Real-time feedback and educational content; Care team portal for providers (Management Portal); SMARTVisit reports for healthcare providers; Data logging capabilities (glucose, BP, weight, sleep, meals, exercise)
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Endocrinology, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and WellDoc BlueStar.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF is an AI algorithm designed to detect reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure. WellDoc BlueStar is an AI-powered digital health solution focused on chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure.
Bunkerhill ECG-EF integrates seamlessly with Electronic Health Records (EHRs) and clinical archives, analyzing routine 12-lead ECG data. WellDoc BlueStar operates as a mobile app (iOS, Android) and web-based platform for patients, with a care team portal for providers to oversee and manage patient data.
Bunkerhill ECG-EF analyzes routine 12-lead ECG data to detect reduced LVEF. WellDoc BlueStar integrates with connected devices such as blood glucose monitors, continuous glucose monitors (CGMs), blood pressure cuffs, and weight scales, and also allows for manual data logging of various health metrics by the patient.
Bunkerhill ECG-EF is specifically focused on detecting reduced LVEF to identify patients at risk for heart failure. WellDoc BlueStar offers multi-condition support, including diabetes, hypertension, heart failure, weight management, and behavioral health.
Bunkerhill ECG-EF is primarily a diagnostic aid for physicians, integrating into their clinical reasoning process for early heart failure risk identification. WellDoc BlueStar's primary user is the patient, who receives AI-driven personalized coaching, real-time feedback, and educational content via a mobile app, with providers overseeing through a management portal.
Bunkerhill ECG-EF requires direct contact with the company for pricing details. WellDoc BlueStar operates on an enterprise pricing model, typically paid for by health plans, health systems, or employers.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.